RT @RichardPAConway: Dr Vargas-Santos reported on risk of gout with SGLT2-inhibitors using THIN database. Canagliflozin
Tweet Content
Dr Vargas-Santos reported on risk of gout with SGLT2-inhibitors using THIN database. Canagliflozin shown in prior RCT to reduce gout risk. Here dapagliflozin and empagliflozin showed even stronger effect @rheumnow #ACR20 Abstr#660 https://t.co/MTjByMmHo7
Show on Archive Page
On
Display in Search Results
On